Doyle Ramona
SEC CIK 1856069 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| RXRX | RECURSION PHARMACEUTICALS, INC. | Chief Medical Off | 121.1K | — | — | 7 | 2022-01-03 | 2022-05-16 |
Most active insiders at RXRX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Borgeson Blake | Dir | — | $4.10M |
| 2 | Gibson Christopher | Dir | — | $3.84M |
| 3 | Khan Najat | Chief R, D Commercial Off, Dir | — | $806.7K |
| 4 | Taylor Ben R | CFO | — | $157.7K |
| 5 | Bumpus Namandje | Dir | — | $28.1K |
| 6 | Michor Franziska | Dir | — | — |
| 7 | Hallett David | CSO | — | — |
| 8 | Dar Zavain | Dir | — | — |
| 9 | Li Dean Y | Dir | — | — |
| 10 | Sun Elaine D | Dir | — | — |
Doyle Ramona made no open-market trades at RXRX in the last 12 months.
Transactions 7
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-05-18 | 2022-05-16 | RXRX | RECURSION PHARMACEUTICALS, INC. | Doyle Ramona | Chief Medical Off | F - Tax | $5.67 | -832 | 121.1K | -0.7% | -$4,717 | |
| D | 2022-04-04 | 2022-03-31 | RXRX | RECURSION PHARMACEUTICALS, INC. | Doyle Ramona | Chief Medical Off | M - OptEx | $2.48 | +9,072 | 121.9K | +8% | +$22.5K |
| D | 2022-03-01 | 2022-02-28 | RXRX | RECURSION PHARMACEUTICALS, INC. | Doyle Ramona | Chief Medical Off | M - OptEx | $2.48 | +15.6K | 112.9K | +16% | +$38.8K |
| DM | 2022-02-08 | 2022-02-04 | RXRX | RECURSION PHARMACEUTICALS, INC. | Doyle Ramona | Chief Medical Off | A - Grant | $0.00 | +40.9K | 95.8K | +74% | $0 |
| D | 2022-02-08 | 2022-02-04 | RXRX | RECURSION PHARMACEUTICALS, INC. | Doyle Ramona | Chief Medical Off | F - Tax | $11.40 | -981 | 97.2K | -1.0% | -$11.2K |
| D | 2022-02-02 | 2022-01-31 | RXRX | RECURSION PHARMACEUTICALS, INC. | Doyle Ramona | Chief Medical Off | M - OptEx | $2.48 | +15.6K | 57.3K | +37% | +$38.8K |
| D | 2022-01-05 | 2022-01-03 | RXRX | RECURSION PHARMACEUTICALS, INC. | Doyle Ramona | Chief Medical Off | M - OptEx | $2.47 | +40.3K | 40.3K | New | +$99.6K |
Purchase Sale Sale after option exercise All abbreviations